The estimated annual average direct and indirect cost of HBP from 2012 to 2013 was $51.2 billion (Benjamin et al., 2017). Managing and treating HBP would reduce cardiovascular disease mortality for males and females by 30.4 percent and 38.0 percent, respectively (Patel et al., 2015). A person who has HBP is four times more likely to die from a stroke and three times more likely to die from heart disease (CDC, 2012) The National Vital Statistics Systems Center for Disease Control and Prevention reported that in 2014 there were approximately 73,300 deaths directly due to HBP and 410,624 deaths with any mention of HBP (CDC, 20145).Between 20 the number of deaths due to HBP rose by 34.1 percent (Benjamin et al., 2017). HBP, known as the “silent killer,” increases risks of heart disease and stroke which are two of the leading causes of death in the U.S. Between 2011-2014 the prevalence of hypertension (>=140/90 mm Hg) among US adults 60 and older was approximately 67.2 percent (Benjamin et al., 2017). High Blood Pressure is common, according to the National Health and Nutrition Examination Survey (NHANES), approximately 85.7 million adults >= 20 years of age had HBP (140/90 mm Hg) between 2011 to 2014 (Crim, 2012. The causes of hypertension are multiple and multifaceted and can be based on genetic predisposition, environmental risk factors, being overweight and obese, sodium intake, potassium intake, physical activity, and alcohol use. High blood pressure (HBP), also known as hypertension, is when the pressure in blood vessels is higher than normal (Centers for Disease Control and Prevention, 2016). ICD-10 copyright 2018 World Health Organization. This material contains SNOMED Clinical Terms(R) (SNOMED CT) copyright 2004-2018 International Health Terminology Standards Development Organisation. LOINC(R) copyright 2004-2018 Regenstrief Institute, Inc. NCQA disclaims all liability for use or accuracy of any third party codes contained in the specifications.ĬPT(R) contained in the Measure specifications is copyright 2004-2018 American Medical Association. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. Limited proprietary coding is contained in the Measure specifications for user convenience. (C) 2012-2019 National Committee for Quality Assurance. All commercial uses or requests for modification must be approved by NCQA and are subject to a license at the discretion of NCQA. Commercial use is defined as the sale, licensing, or distribution of the Measure for commercial gain, or incorporation of the Measure into a product or service that is sold, licensed or distributed for commercial gain. The Measure can be reproduced and distributed, without modification, for noncommercial purposes (eg, use by healthcare providers in connection with their practices) without obtaining approval from NCQA. NCQA makes no representations, warranties, or endorsement about the quality of any organization or physician that uses or reports performance measures and NCQA has no liability to anyone who relies on such measures or specifications. NCQA is not responsible for any use of the Measure. This Physician Performance Measure (Measure) and related data specifications are owned and were developed by the National Committee for Quality Assurance (NCQA).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |